Physical activity trajectories and associated factors in patients with lung cancer undergoing chemotherapy: A longitudinal study
Asia-Pacific Journal of Oncology Nursing · 2026-12 · 13 · 100977
DOI: 10.1016/j.apjon.2026.100977 ↗Kurz gefasst
Fachartikel in der Zeitschrift Asia-Pacific Journal of Oncology Nursing, 2026-12. Verfasst von Ziyi Cao und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Nursing, Anhui Medical University, Hefei, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Anhui Medical University, National Natural Science Foundation of China.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Objective
To characterize heterogeneity in physical activity (PA) trajectories among patients with lung cancer during early chemotherapy and examine associated demographic, clinical, and psychosocial factors.
Methods
This longitudinal study enrolled 155 patients initiating chemotherapy at the First Affiliated Hospital of Anhui Medical University in Anhui Province, China. PA was assessed using the International Physical Activity Questionnaire-Short Form at baseline and before the second, third, and fourth cycles. Symptom burden, exercise self-efficacy, outcome expectations for exercise, and social support were assessed exclusively at baseline. Latent class growth analysis was utilized to identify PA trajectories. Factors associated with trajectory membership were analyzed using a two-stage strategy combining least absolute shrinkage and selection operator regression and Firth's penalized logistic regression.
Results
Among 122 completers, two distinct trajectories were identified. The majority (77.9%) followed a "Moderate-Sustained Decline" trajectory, showing a significant drop at cycle 2 with persistently low activity. Conversely, 22.1% exhibited a "High-Decline-Partial Recovery" trajectory, characterized by a behavioral rebound after the initial decline. Multivariate analysis revealed that higher symptom burden (OR = 1.105, P = 0.028) and more pessimistic outcome expectations (OR = 1.723, P = 0.005) increased the likelihood of sustained decline. Higher exercise self-efficacy (OR = 0.855, P = 0.003) was significantly associated with the partial recovery profile.
Conclusions
PA patterns are heterogeneous, though a decline prior to the second cycle is universal. Lower symptom burden and stronger cognitive resources may support more favorable physical activity trajectories. Proactive nursing interventions integrating symptom management with cognitive-behavioral empowerment targeting the critical window before the second cycle are recommended to prevent functional decline.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Nursing, Anhui Medical University, Hefei, China.
- The First Affiliated Hospital of Anhui Medical University, Hefei, China.
- Nursing International Collaboration Research Center of Anhui Province, Hefei, China.
Förderung
- Anhui Medical University
- National Natural Science Foundation of China
Zitieren
APA
Cao, Z., Ding, M., Xu, Q., Zhang, Y., Wang, Z., & Hong, J. (2026). Physical activity trajectories and associated factors in patients with lung cancer undergoing chemotherapy: A longitudinal study. Asia-Pacific Journal of Oncology Nursing, 13, 100977. https://doi.org/10.1016/j.apjon.2026.100977
Vancouver
Cao Z, Ding M, Xu Q, Zhang Y, Wang Z, Hong J. Physical activity trajectories and associated factors in patients with lung cancer undergoing chemotherapy: A longitudinal study. Asia-Pacific Journal of Oncology Nursing. 2026;13:100977. doi:10.1016/j.apjon.2026.100977
BibTeX
@article{Cao2026,
author = {Cao, Ziyi and Ding, Man and Xu, Qin and Zhang, Yuhan and Wang, Zhuzhu and Hong, Jingfang},
title = {Physical activity trajectories and associated factors in patients with lung cancer undergoing chemotherapy: A longitudinal study},
journal = {Asia-Pacific Journal of Oncology Nursing},
year = {2026},
volume = {13},
pages = {100977},
doi = {10.1016/j.apjon.2026.100977}
}
EUVIMED